Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natarajan Ravendhran

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Translational Gastroenterology and Hepatology|January 27, 2023
Association between body mass index and liver stiffness measurement using transient elastography in patients with non-alcoholic fatty liver disease in a hepatology clinic: a cross sectional studyHarish Gopalakrishna, Oluwaseun E Fashanu, Gayatri B Nair, et al.
European Journal of Gastroenterology & Hepatology|February 26, 2024
Optimizing surveillance of low-risk metabolic dysfunction associated steatotic liver disease using transient elastographyHarish Gopalakrishna, Gayatri B Nair, Roham Salman Roghani, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|July 8, 2025
Association of Carbohydrate Antigen 19-9 Elevation Among Patients With Alcohol-Related Liver Disease Undergoing Liver TransplantLynette M Sequeira, Merve Gurakar, Ahmet Gurakar, et al.
Hepatology (Baltimore, Md.)|December 27, 2018
Financial Compensation For Hepatologists in Different Practice SettingsMitchell L Shiffman, Norman L Sussman, Natarajan Ravendhran, et al.
Alimentary Pharmacology & Therapeutics|December 13, 2022
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitisZobair Younossi, Naim Alkhouri, Ken Cusi, et al.
BMC Gastroenterology|April 6, 2016
Implementation of baby boomer hepatitis C screening and linking to care in gastroenterology practices: a multi-center pilot studyZobair M Younossi, Louis L LaLuna, John J Santoro, et al.
The American Journal of Gastroenterology|April 27, 2018
Elbasvir/grazoprevir in black adults with hepatitis C virus infection: a pooled analysis of phase 2/3 clinical trialsPhilippe J Zamor, John Vierling, Reem Ghalib, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 19, 2016
On-treatment HCV RNA as a predictor of sustained virological response in HCV genotype 3-infected patients treated with daclatasvir and sofosbuvirKris V Kowdley, David R Nelson, Jacob P Lalezari, et al.
Viruses|October 28, 2023
Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated CirrhosisSteven Flamm, Eric Lawitz, Brian Borg, et al.
Journal of Viral Hepatitis|April 14, 2019
Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low-dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosisFred Poordad, Shahriar Sedghi, Paul J Pockros, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Translational Gastroenterology and Hepatology|January 27, 2023
Association between body mass index and liver stiffness measurement using transient elastography in patients with non-alcoholic fatty liver disease in a hepatology clinic: a cross sectional studyHarish Gopalakrishna, Oluwaseun E Fashanu, Gayatri B Nair, et al.
European Journal of Gastroenterology & Hepatology|February 26, 2024
Optimizing surveillance of low-risk metabolic dysfunction associated steatotic liver disease using transient elastographyHarish Gopalakrishna, Gayatri B Nair, Roham Salman Roghani, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|July 8, 2025
Association of Carbohydrate Antigen 19-9 Elevation Among Patients With Alcohol-Related Liver Disease Undergoing Liver TransplantLynette M Sequeira, Merve Gurakar, Ahmet Gurakar, et al.
Hepatology (Baltimore, Md.)|December 27, 2018
Financial Compensation For Hepatologists in Different Practice SettingsMitchell L Shiffman, Norman L Sussman, Natarajan Ravendhran, et al.
Alimentary Pharmacology & Therapeutics|December 13, 2022
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitisZobair Younossi, Naim Alkhouri, Ken Cusi, et al.
BMC Gastroenterology|April 6, 2016
Implementation of baby boomer hepatitis C screening and linking to care in gastroenterology practices: a multi-center pilot studyZobair M Younossi, Louis L LaLuna, John J Santoro, et al.
The American Journal of Gastroenterology|April 27, 2018
Elbasvir/grazoprevir in black adults with hepatitis C virus infection: a pooled analysis of phase 2/3 clinical trialsPhilippe J Zamor, John Vierling, Reem Ghalib, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 19, 2016
On-treatment HCV RNA as a predictor of sustained virological response in HCV genotype 3-infected patients treated with daclatasvir and sofosbuvirKris V Kowdley, David R Nelson, Jacob P Lalezari, et al.
Viruses|October 28, 2023
Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated CirrhosisSteven Flamm, Eric Lawitz, Brian Borg, et al.
Journal of Viral Hepatitis|April 14, 2019
Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low-dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosisFred Poordad, Shahriar Sedghi, Paul J Pockros, et al.
Pageof 3